THROSBY, MARK,GEUIJEN, CECILIA ANNA WILHELMINA,MAUSSANG-DETAILLE, DAVID ANDRE BAPTISTE,LOGTENBERG, TON
申请号：
CA3058341
公开号：
CA3058341A1
申请日:
2018.04.03
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention relates to the field of antibodies. In particular it relates to the field of therapeutic (human) antibodies for the treatment of ErbB-2/ErbB-3 positive tumor. More in particular it relates to treating tumors with a high ErbB-2/ErbB-3 cell-surface receptor ratio. Also encompassed are methods for treating patients not previously treated with an ErbB-2 specific therapy or with an ErbB-3 specific therapy.
